Zhou J, Sun H, Wang Z, Cong W, Zeng M, Zhou W, et al. (2023) Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition). Liver Cancer. 12(5):405–444.

PubMed  PubMed Central  Google Scholar 

European Association for the Study of the Liver. (2018). EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 69(1):182–236.

Kim TH, Kim SY, Tang A, Lee JM. (2019) Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin Mol Hepatol. 25(3):245–263.

PubMed  PubMed Central  Google Scholar 

American College of Radiology. LI-RADS Ultrasound Surveillance [EB/OL]. (2024)[2025-2-17]. https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Reporting-and-Data-Systems/LI-RADS

Marrero JA, Mulik L, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 68:723–750.

PubMed  Google Scholar 

Kim TK, Noh SY, Wilson SR, Kono Y, Piscaglia F, Jang HJ, et al. (2017) Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system. Clin Mol Hepatol.23(4):280–289.

PubMed  PubMed Central  Google Scholar 

Goto E, Masuzaki R, Tateishi R, Kondo Y, Imamura J, Goto T, et al. (2012) Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. J Gastroenterol. 47:477–485.

PubMed  Google Scholar 

Lee JY, Minami Y, Choi BI, Lee WJ, Chou YH, Jeong WK, et al. (2020) The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Ultrasonography. 39(3):191–220.

PubMed  PubMed Central  Google Scholar 

Mitchell DG, Bruix J, Sherman M, Sirlin CB. (2015) LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology. 61(3):1056–1065.

PubMed  Google Scholar 

Choi SH, Lee S, Park SH, Kim KM, Yu E, Park Y, et al. (2018) LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI. Radiology. 290:1–10.

Google Scholar 

Kono Y, Lyshchik A, Cosgrove D, Dietrich CF, Jang HJ, Kim TK, et al. (2017) Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR). Ultraschall in Med. 38: 85–86.

Google Scholar 

Ding J, Long L, Zhang X, Chen C, Zhou H, Zhou Y, et al. (2021) Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS. Eur Radiol. 31(2):1–8.

Google Scholar 

Zheng W, Li Q, Zou XB, Wang JW, Han F, Li F, et al. (2020) Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B Infection. Radiology. 294(2): 1–9.

Google Scholar 

Kang HJ, Lee J, Yoon JH, Lee K, Kim H, Han JK. (2020) Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk. Radiology. 297(1): 1–9.

Google Scholar 

Li L, Zheng W, Wang J, Han J, Guo Z, Hu Y, et al. (2022) Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection. AJR Am J Roentgenol. 219(3):434–443.

PubMed  Google Scholar 

Lv K, Zhai H, Jiang Y, Liang P, Xu HX, Du L, et al. (2021) Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue((R)) ultrasound contrast agents in patients with focal liver lesions. Abdom Radiol (NY). 46(10):4647–4659.

PubMed  PubMed Central  Google Scholar 

Zhai HY, Liang P, Yu J, Cao F, Kuang M, Liu FY, et al. (2019) Comparison of Sonazoid and SonoVue in the Diagnosis of Focal Liver Lesions: A Preliminary Study. J Ultrasound Med. 38(9):2417–2425.

PubMed  Google Scholar 

Li L, Zou X, Zheng W, Li Y, Xu X, Li K, et al. (2023) Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma. Radiology. 308(2):e230150.

PubMed  Google Scholar 

Cai WJ, Ying M, Zheng RQ, Liao J, Luo B, Tang L, et al. (2023) Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Hepatocellular Carcinoma ≤ 5 cm: Biological Characteristics and Patient Outcomes. Liver Cancer. 12(4):356–371.

CAS  PubMed  PubMed Central  Google Scholar 

Jeong B, Choi SJ, Choi SH, Jang HJ, Byun JH, Won HJ, et al. (2024) LI-RADS threshold growth based on tumor growth rate can improve the diagnosis of hepatocellular carcinoma ≤ 3.0 cm. Eur Radiol. 34(2):1210–1218.

PubMed  Google Scholar 

Huang Z, Zhou PP, Li SS, Li KY. (2022) Prediction of the Ki-67 marker index in hepatocellular carcinoma based on Dynamic Contrast-Enhanced Ultrasonography with Sonazoid. Insights Imaging. 13(1):199.

PubMed  PubMed Central  Google Scholar 

Goins SM, Jiang H, van der Pol CB, Salameh JP, Lam E, Adamo RG, et al. (2023) Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis. Radiology. 309(3):e231656.

PubMed  Google Scholar 

Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics. 28(3):747–69.

PubMed  Google Scholar 

Gu JH, He MN, Xu M, Chen SC, ZHU L, He C, et al. (2020) Diagnostic Value of SonoVue and Sonazoid in Hepatocellular Carcinoma Based on Time Intensity Curve. Chinese Journal of Ultrasound in Medicine. 36(12):1133–1136.

Google Scholar 

Wang Y, Zhu GQ, Zhou CW, Li N, Yang C, Zeng MS. (2022) Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors. Eur Radiol. 32(8):5166–5178.

CAS  PubMed  Google Scholar 

Dietrich CF, Nolsoe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, et al. (2020) Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med. 41(5):562–585.

PubMed  Google Scholar 

Ren J, Lu Q, Fei X, Dong Y, D Onofrio M, Sidhu PS, et al. (2024) Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®. Eur Radiol. 34(6):3795–3812.

PubMed  Google Scholar 

Sugimoto K, Kamiyama N, Kakegawa T, Takahashi H, Wada T, Abe M, et al. (2023) Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma. Ultrasonography. 42(3):388–399.

PubMed  PubMed Central  Google Scholar